RETRACTED: Baicalin Prevents Myocardial Ischemia/Reperfusion Injury Through Inhibiting ACSL4 Mediated Ferroptosis

Fan, Zhenyu; Cai, Liangliang; Wang, Shengnan; Wang, Jing; Chen, Bohua

doi:10.3389/fphar.2021.628988

ORIGINAL RESEARCH article

Front. Pharmacol., 14 April 2021

Sec. Cardiovascular and Smooth Muscle Pharmacology

Volume 12 - 2021 | https://doi.org/10.3389/fphar.2021.628988

RETRACTED: Baicalin Prevents Myocardial Ischemia/Reperfusion Injury Through Inhibiting ACSL4 Mediated Ferroptosis

Retracted

A retraction of this article was approved in:

Retraction: Baicalin prevents myocardial ischemia/reperfusion injury through inhibiting ACSL4 mediated ferroptosis
1. Read retraction

Zhenyu Fan

Liangliang Cai

Shengnan Wang

Jing Wang

Bohua Chen*

Department of Pharmacy, Affiliated Hospital of Nantong University, Nantong, China

This article has been retracted. Please follow the link to the full Retraction notice for details.

Citation: Fan Z, Cai L, Wang S, Wang J and Chen B (2021) Baicalin Prevents Myocardial Ischemia/Reperfusion Injury Through Inhibiting ACSL4 Mediated Ferroptosis. Front. Pharmacol. 12:628988. doi: 10.3389/fphar.2021.628988

Received: 13 November 2020; Accepted: 01 March 2021;
Published: 14 April 2021; Retracted: 03 February 2026.

Edited by:

Liberato Berrino, University of Campania Luigi Vanvitelli, Italy

Reviewed by:

Jian Yang, The First People's Hospital of Yichang, China
Sarawut Kumphune, Chiang Mai University, Thailand

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.